Frontlight ResearchEarly access
Pancreatic cancer trials in South Korea
55 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Where
- Hwasun, Seoul
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00 - No phaseNot yet taking people in South KoreaGenomic Profiling of Pancreatic Cystic Tumors
- Where
- Seoul
- Age
- 19 years and over
- People
- 250
- Run by
- Samsung Medical Center
See details and how to joinNCT06195904 - No phaseTaking peopleThe Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
- Where
- Seoul
- Age
- 18 years and over
- People
- 1,000
- Run by
- Samsung Medical Center
See details and how to joinNCT03637569 - Phase 3Taking peopleSafety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 408
- Run by
- GC Cell Corporation
See details and how to joinNCT04969731 - No phaseEnrolling by invitationProspective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
- Where
- Goyang-si
- Age
- 19 years and over
- People
- 120
- Run by
- National Cancer Center, Korea
See details and how to joinNCT04466189